NS · Financial Services

Biogen Pharmachem Industries Ltd (531752)

Finance

Biogen Pharmachem Industries Ltd (531752) is listed on NS in the Financial Services sector. Industry: Finance. As of 2026-07-10, reported market cap is $417.70M, P/E ratio is 34.00, net margin is 26.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 531752

Market cap

$417.70M

P/E ratio

34.00

Net margin

26.6%

Biogen Pharmachem Industries Ltd (531752) — FAQ

What is Biogen Pharmachem Industries Ltd's market cap?

Biogen Pharmachem Industries Ltd (531752) has a reported market cap of $417.70M (data as of 2026-07-10).

What is 531752's P/E ratio?

The price-to-earnings (P/E) ratio for Biogen Pharmachem Industries Ltd (531752) is 34.00 (data as of 2026-07-10).

Does Biogen Pharmachem Industries Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Biogen Pharmachem Industries Ltd (531752). Check the MyAverix Finance app for the latest dividend data.

What sector is Biogen Pharmachem Industries Ltd in?

Biogen Pharmachem Industries Ltd (531752) is classified in the Financial Services sector (Finance industry).

What exchange is 531752 listed on?

531752 is listed on NS.

What is Biogen Pharmachem Industries Ltd's net margin?

Biogen Pharmachem Industries Ltd (531752) reports a net margin of 26.6% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Financial Services companies

029 GROUP SE INH O.N. (Z29) 1867 Western Financial Corp (WFCL) 1895 of Wisconsin Inc Bancorp (BCOW) 1RT Acquisition Corp. (ONCH) 1st Colonial Bancorp Inc (FCOB) 3330 (3330) 360 Capital Group (TGP) 360 DigiTech Inc. (3660)